KRAS Mutation Variants and Co-occurring PI3K Pathway Alterations Impact Survival for Patients with Pancreatic Ductal Adenocarcinomas
Author(s) -
Adam Diehl,
Lindsay M. Hannan,
David B. Zhen,
Andrew L. Coveler,
Gentry Teng King,
Stacey A. Cohen,
William P. Harris,
Veena Shankaran,
Kit Man Wong,
Steven M. Green,
Natasha Hui Jin Ng,
Venu G. Pillarisetty,
Jonathan G. Sham,
James O. Park,
Deepti Reddi,
Eric Q. Konnick,
Colin C. Pritchard,
Kelsey Baker,
Mary W. Redman,
E. Gabriela Chiorean
Publication year - 2022
Publication title -
the oncologist
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.176
H-Index - 164
eISSN - 1549-490X
pISSN - 1083-7159
DOI - 10.1093/oncolo/oyac179
Subject(s) - kras , medicine , pancreatic cancer , oncology , cancer research , proportional hazards model , pi3k/akt/mtor pathway , cancer , colorectal cancer , genetics , biology , apoptosis
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom